2012

Harvard stem cell researchers and scientists at the University of Cambridge in the United Kingdom have found that the age-related degeneration in conditions such as multiple sclerosis (MS) may be reversible. The researchers, co-led by Associate Professor...

The prime mandate of the Center for Human Cell Therapy (CHCT) is to provide resources to investigators to facilitate bench-to-bedside development of novel cellular therapies for the treatment of human diseases (www.chct.org). CHCT is part of the...

Overview: The Harvard Stem Cell Institute (HSCI) is now accepting applications for one (1) Post-doctoral fellow to be funded by the HSCI’s NIH Training Grant. Training Grant appointments cover the following costs: • Stipend (amount determined by NIH...

Overview: The Harvard Stem Cell Institute (HSCI) is now accepting applications for two (2) Graduate student fellows to be funded by the HSCI’s NIH Training Grant. Training Grant appointments cover the following costs: • Stipend (amount determined by NIH...

The Harvard Stem Cell Institute (HSCI) Translational Program invites applications for Pilot Grant funding for 2012. The purpose of this funding program is to provide resources for proof-of-concept, preclinical research studies ultimately aimed at...

Application deadline: Thursday, May 3, 2012 The Harvard Stem Cell Institute (HSCI) Cardiovascular Program invites applications for Pilot Grants for 2012. The purpose of this funding program is to provide resources for research in cardiovascular disease...

Application deadline: Tuesday, May 1, 2012 The Harvard Stem Cell Institute (HSCI) invites applications for Pilot Grant funding for 2012 under the NIH-funded P01 grant "Dissecting the establishment and regulation of human pluripotency" (PI Alexander...

Application deadline: Friday, May 25, 2012 The Harvard Stem Cell Institute (HSCI) Diabetes Program invites applications for Pilot Grants for 2012 in the area of Type 1 Diabetes (T1D). The purpose of this funding program is to provide resources for...

Harvard stem cell researchers at Massachusetts General Hospital (MGH) have taken a critical step toward discovering in the relatively near future a drug to control cystic fibrosis (CF), a fatal lung disease that claims about 500 lives each year, with 1...